Current Opinion in Urology

Papers
(The H4-Index of Current Opinion in Urology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial introductions75
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies52
Research frontiers in urology51
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects47
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker28
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis27
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma23
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update23
The role of innovations in advancing urologic oncologic patient care20
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments20
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology20
Tissue-based gene expression testing in localized prostate cancer19
Editorial introductions17
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder17
Editorial introductions16
Testicular cancer with small metastatic burden: optimal approach in 202415
Editorial introductions15
RNA-based urinary assays for non-muscle invasive bladder cancer15
0.09572696685791